<qa>  How many subjects are diagnosed with HIV?The study will be conducted at a single investigative center AIDS ReSearch Alliance, West Hollywood, CA. Six subjects with a diagnosis of HIV who are also receiving triple combination antiretroviral therapy and have been so doing for a minimum of 2 months are planned per group. Patients will be admitted to an in-patient facility for 72 hours. After an initial night to acclimate the patients to the facility, a 24-hour measurement of cortisol secretion in blood and urine will be conducted. After this is complete, patients will receive an initial single dose of SP01A orally. 200 mg SP-01A for group A, 400 mg for group B, 600 mg for group C, and 800 mg for group D. Blood and urine samples will also be collected for 24 hours to further evaluate the safety of the study medication. Patients will then be discharged from the facility. 